Loading clinical trials...
Loading clinical trials...
Observational Study of the Use of Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) Under Real-Life Setting in Austria, Germany and Switzerland
Conditions
Locations
70
Austria
Universitaetsklinikum St. Poelten /ID# 221152
Sankt Pölten, Lower Austria, Austria
Medizinische Universitaet Graz /ID# 221155
Graz, Styria, Austria
Landeskrankenhaus Salzburg-Universitaetsklinikum der PMU (LKH) /ID# 221153
Salzburg, Austria
Hanusch Krankenhaus /ID# 221151
Vienna, Austria
Stauferklinikum Schwaebisch Gmuend /ID# 201518
Mutlangen, Baden-Wurttemberg, Germany
Onkologische Praxis /ID# 201545
Stuttgart, Baden-Wurttemberg, Germany
Start Date
December 4, 2017
Primary Completion Date
December 1, 2030
Completion Date
December 1, 2030
Last Updated
December 8, 2025
NCT07030400
NCT06043011
NCT06528301
NCT05168930
NCT04758975
NCT04488354
Lead Sponsor
AbbVie
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions